Literature DB >> 6429035

B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis.

S Al-Balaghi, H Ström, E Möller.   

Abstract

In this paper we have summarized our findings on immune activity in patients with Rheumatoid Arthritis. RA is characterized not only by the formation of various autoantibodies but also of a hyperreactivity of the B cell system, shown as an increased DNA synthetic rate of blood non-T, non-monocytic lymphocytes as well as an increased number of actively antibody secreting cells both in the blood and the synovial fluid. Synovial fluid contains biological activity which synergizes with PWM for the induction of Ig-secreting cells in blood from healthy controls. The factor can also substitute for T cells in the PWM-induced antibody synthesis in vitro. This activity fits well with the finding that SF contains a factor which induces increased formation of IgG in LPS-pretreated mouse cell cultures. Experiments show that the factor leads to a preferential increase in the production of IgG2b antibody secreting cells. Therefore, we conclude that synovial fluid contains a B cell differentiating factor with a selective effect on the induction of a particular IgG subclass.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429035     DOI: 10.1111/j.1600-065x.1984.tb00474.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  14 in total

Review 1.  B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression.

Authors:  T Kishimoto
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

Review 2.  Autoimmune conditions induced by epithelial solid tumors.

Authors:  R Bataille; B Klein
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

3.  Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue.

Authors:  E D Silverman; B Isacovics; D Petsche; R M Laxer
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

4.  Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis.

Authors:  S Al-Balaghi; H Ström; E Möller
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

5.  Correlation of anti-cytoskeleton antibody activities in synovial fluid with interleukin-6 in patients with osteoarthritis and inflammatory joint disease.

Authors:  W J Mayet; E Hermann; M Bachmann; M Manns; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1990-07-05

6.  Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells.

Authors:  S Kumagai; H Ishida; K Iwai; T Tsubata; H Umehara; S Ozaki; T Suginoshita; S Araya; H Imura
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 7.  Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?

Authors:  Vivianne Malmström; Christina Trollmo; Lars Klareskog
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

8.  Detection and partial characterization of human B cell colony stimulating activity in synovial fluids of patients with rheumatoid arthritis.

Authors:  A C Fay; A Trudgett; J D McCrea; F Kirk; J M Thompson; E S Mitchell; M J Boyd; S D Roberts; T A McNeill
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha.

Authors:  S C Thornton; S B Por; R Penny; M Richter; L Shelley; S N Breit
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

10.  Characterization of IL-2 responsive synovial T lymphocytes in rheumatoid arthritis. II. Functional properties.

Authors:  W A Ofosu-Appiah; R J Warrington; J A Wilkins
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.